Better choice to explore non-equity related capital solutions to fund the r&d of its domestic animal targeted glp1 supplement

New york, march 04, 2024 (globe newswire) -- better choice company (nyse: bttr) (“better choice” or “the company”), a pet health and wellness company, today announced that after successfully completing the acquisition of aimia, the company will explore and evaluate proposals to monetize and fund ownership in its r&d platform with the goal to bring in partners to participate in the evolution of a treat-based glp1 supplement to combat obesity in dogs and cats.
BTTR Ratings Summary
BTTR Quant Ranking